Faculty of Medicine

Z7_NQ5E12C0LOF160QDKRNCOGGJA1

Research group

Spanish

Group of Rheumatology Universidad de Antioquia GRUA

Academic Unit: Faculty of Medicine

Colombian Ministry of Science

C

Call

894 GrupLAC

OECD

Area

Medical and health sciences

Subarea

Clinical medicine

Download Fact Sheet

Strategic Focus

Our group’s mission is to research rheumatology, especially systemic lupus erythematosus and primary vasculitis. It also aims to train specialists on rheumatology and carry out rheumatology-care related activities such as hospitalization and external consultancy. We also aim to create an autoimmunity laboratory in a conjoint effort with the School of Medicine’s GICIG (Cellular Immunology and Immunogenetics) group.

Research Lines and/or Areas

Clinical and therapeutic aspects of systemic lupus erythematosus.
Autoimmunity.
Young dermatomyositis.
Rheumatic diseases in children in the context of intensive care.
Latin American Group for Lupus Study (GLADELGrupo Latinoamericano para el estudio del lupus).
Lupus erythematosus and infection.
Pediatric rheumatology.
Validation of instruments for monitoring rheumatic patients in external consultancy.
Levamisole-adulterated cocaine-induced vasculitis (LACIV).
Primary systemic vasculitis.

Sustainable Development Goals (SDGs)

Group Coordinator

Luis Alonso González Naranjo MD

Specialization in Internal Medicine and Rheumatology

Universidad de Antioquia

Lupus Research Fellow of the STELLAR

University of Alabama at Birmingham, United States

Scientific Cooperation

Collaborative Relationships

The Rheumatology Group from Universidad de Antioquia is currently engaged in clinical research on primary vasculitis and systemic lupus erythematosus. The group members are also part of GLADEL group, which has various headquarters over Latin America, where it studies systemic lupus erythematosus. They are currently part of various research projects carried out by GLADEL, such as the one investigating lupus nephritis biomarkers. The group has also worked together on research projects with rheumatologists from the Clinic Hospital of Barcelona, Spain. Additionally, the group is working on a conjoint, ongoing research project with Cellular Immunology and Immunogenetics Group from Universidad de Antioquia.

Highlighted Projects

Tuberculosis-associated factors in systemic lupus erythematosus patients.
Mortality in lupus erythematosus patients in intensive care unit.
Obstetric outcomes in women with Takayasu's arteritis.
nosocomial bacterial infection in patients with systemic lupus erythematosus.
Levamisole-adulterated cocaine-induced vasculitis (LACIV).

Key Research Findings

Factors associated with active tuberculosis in Colombian patients with systemic lupus erythematosus: a case-control study. https://doi.org/10.1007/s10067-020-05225-x
Desenlaces obstétricos en pacientes con arteritis de Takayasu: serie de casos. (Obstetric Outcomes in Women With Pulseless Disease: Case Series.) https://doi.org/10.1016/j.rcreu.2020.04.003
Development and internal validation of a clinical prediction model of the risk of nosocomial bacterial infection in patients with systemic lupus erythematosus. DOI: 10.1016/j.rcreu.2020.07.005
Clinical Profile of Levamisole-Adulterated Cocaine-Induced Vasculitis/Vasculopathy: A 30-Case Series. DOI:10.1097/RHU.0000000000000813